Literature DB >> 6692309

Lung cancer in nonsmokers.

G C Kabat, E L Wynder.   

Abstract

Among 2668 patients with newly diagnosed lung cancer interviewed between 1971 and 1980, 134 cases occurred in "validated" nonsmokers. The proportion of nonsmokers among all cases was 1.9% (37 of 1919) for men and 13.0% (97 of 749) for women, giving a sex ratio of 1:2.6. Kreyberg Type II (mainly adenocarcinoma) was more common among nonsmoking cases, especially women, than among all lung cancer cases. Comparison of cases with equal numbers of age-, sex-, race-, and hospital-matched nonsmoking controls showed no differences by religion, proportion of foreign-born, marital status, residence (urban/rural), alcohol consumption or Quetelet's index. Male cases tended to have higher proportions of professionals and to be more educated than controls. No differences in occupation or occupational exposure were seen in men. Among women, cases were more likely than controls to have worked in a textile-related job (relative risk = 3.10, 95% confidence interval 1.11-8.64), but the significance of this finding is not clear. Preliminary data on exposure to passive inhalation of tobacco smoke, available for a subset of cases and controls, showed no differences except for more frequent exposure among male cases than controls to sidestream tobacco smoke at work. The need for more complete information on exposure to secondhand tobacco smoke is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6692309     DOI: 10.1002/1097-0142(19840301)53:5<1214::aid-cncr2820530532>3.0.co;2-8

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  31 in total

1.  Chasing Ernst L Wynder: 40 years of Philip Morris' efforts to influence a leading scientist.

Authors:  N Fields; S Chapman
Journal:  J Epidemiol Community Health       Date:  2003-08       Impact factor: 3.710

Review 2.  Passive smoking: a review of medical and legal issues.

Authors:  J C Byrd; R S Shapiro; D L Schiedermayer
Journal:  Am J Public Health       Date:  1989-02       Impact factor: 9.308

3.  Lung cancer risk and workplace exposure to environmental tobacco smoke.

Authors:  Leslie Stayner; James Bena; Annie J Sasco; Randall Smith; Kyle Steenland; Michaela Kreuzer; Kurt Straif
Journal:  Am J Public Health       Date:  2007-01-31       Impact factor: 9.308

4.  Does breathing other people's tobacco smoke cause lung cancer?

Authors:  N J Wald; K Nanchahal; S G Thompson; H S Cuckle
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-08

5.  Lung cancer in lifelong non-smokers. Edinburgh Lung Cancer Group.

Authors:  S Capewell; R Sankaran; D Lamb; M McIntyre; M F Sudlow
Journal:  Thorax       Date:  1991-08       Impact factor: 9.139

6.  Lung cancer from passive smoking at work.

Authors:  A J Wells
Journal:  Am J Public Health       Date:  1998-07       Impact factor: 9.308

7.  Active and passive exposure status to tobacco smoke of department store employees measured by cotinine ELISA.

Authors:  N Yoshioka; K Yonemasu; Y Dohi; T Sakanashi; R Mizutani; N Kurumatani; Y Zheng; T Ohkado
Journal:  Environ Health Prev Med       Date:  1998-07       Impact factor: 3.674

8.  EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib.

Authors:  William Pao; Vincent Miller; Maureen Zakowski; Jennifer Doherty; Katerina Politi; Inderpal Sarkaria; Bhuvanesh Singh; Robert Heelan; Valerie Rusch; Lucinda Fulton; Elaine Mardis; Doris Kupfer; Richard Wilson; Mark Kris; Harold Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-25       Impact factor: 11.205

Review 9.  Lung cancer from passive smoking: hypothesis or convincing evidence?

Authors:  K Uberla
Journal:  Int Arch Occup Environ Health       Date:  1987       Impact factor: 3.015

10.  Previous cancer and radiotherapy as risk factors for lung cancer in lifetime nonsmokers.

Authors:  G C Kabat
Journal:  Cancer Causes Control       Date:  1993-09       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.